Erasca Shares Are Trading Higher After the Company Announced That It Entered Into Exclusive License Agreements for Two Preclinical RAS Programs
Erasca宣佈爲兩個臨床前RAS項目簽訂獨家許可協議後,該公司股價走高
Erasca Shares Are Trading Higher After the Company Announced That It Entered Into Exclusive License Agreements for Two Preclinical RAS Programs
Erasca宣佈爲兩個臨床前RAS項目簽訂獨家許可協議後,該公司股價走高
使用瀏覽器的分享功能,分享給你的好友吧